| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/02/2013 | CN102858801A Neutralizing prolactin receptor antibodies and their therapeutic use |
| 01/02/2013 | CN102858799A Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosa |
| 01/02/2013 | CN102858798A Methods for screening antibodies |
| 01/02/2013 | CN102858796A Oligomer-specific amyloid beta epitope and antibodies |
| 01/02/2013 | CN102858371A Antigen Binding Proteins Specific For Serum Amyloid P Component |
| 01/02/2013 | CN102858370A Polysaccharide conjugation with detoxified E. COLI heat labile enterotoxin (LT) used as vaccine |
| 01/02/2013 | CN102858369A Avian group d rotavirus |
| 01/02/2013 | CN102858368A Universal virus-like particle (vlp) influenza vaccines |
| 01/02/2013 | CN102858367A Composite body for antigen or drug delivery |
| 01/02/2013 | CN102858366A Solution Preparation Containing Stabilized Antibody |
| 01/02/2013 | CN102858365A 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition |
| 01/02/2013 | CN102858348A Heterochain aliphatic poly-n-oxide copolymers and vaccinating agents and drugs based thereon |
| 01/02/2013 | CN102858335A Use of ERBB3 inhibitors in the treatment of triple negative and basal-like breast cancers |
| 01/02/2013 | CN102858322A Hydrophilic filtration during manufacture of vaccine adjuvants |
| 01/02/2013 | CN102851313A Hepatitis b vaccine and preparation technology thereof |
| 01/02/2013 | CN102851258A Recombination influenza virus of high-efficiency-expression HA (hemagglutinin) protein and preparation method and application of recombination influenza virus |
| 01/02/2013 | CN102851257A Attenuated vaccine strain for avian infectious bronchitis virus and application thereof |
| 01/02/2013 | CN102851256A In vitro culture method for promoting maturation of dendritic cells and special culture medium for the same |
| 01/02/2013 | CN102851249A Haemophilus parasuis LZ-20100109 strain and application thereof |
| 01/02/2013 | CN102850457A Autoimmune disease anti-autoantibody antibody and its preparation method and application |
| 01/02/2013 | CN102850456A Humanized monoclonal antibody of vascular endothelial growth factor as well as preparation method and application thereof |
| 01/02/2013 | CN102850455A Anti-glypican-3 antibody |
| 01/02/2013 | CN102850454A Anti-RSV (respiratory syncytial virus) human monoclonal antibody, and its preparation method |
| 01/02/2013 | CN102850435A Peptide vaccines for cancers expressing MPHOSP1 or DEPDC1 polypeptides |
| 01/02/2013 | CN102850434A Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides |
| 01/02/2013 | CN102850433A Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides |
| 01/02/2013 | CN102847172A Preparation method of genetic engineering vaccine for preventing staphylococcus caprae mastitis application |
| 01/02/2013 | CN102847169A Megalocytivirus DNA (deoxyribonucleic acid) vaccine, as well as construction and application thereof |
| 01/02/2013 | CN102847168A Design and construction of nucleic acid vaccine PV-Fn for preventing cow mastitis |
| 01/02/2013 | CN102847167A Construction of improved synergetic nucleic acid vaccine for preventing cow mastitis |
| 01/02/2013 | CN102847154A Therapeutic uses of inhibitors of RTP801 |
| 01/02/2013 | CN102847149A Methods of treating autoimmune and inflammatory diseases |
| 01/02/2013 | CN102847148A Antibodies binding to an intracellular PRL-1 OR PRL-3 polypeptide |
| 01/02/2013 | CN102847147A Combined live vaccine for muscovy duck parvovirus disease and muscovy duck reovirus disease |
| 01/02/2013 | CN102847146A Vaccine used for preventing tilapia streptococcal disease |
| 01/02/2013 | CN102847145A Method for preparing dendritic cell vaccine |
| 01/02/2013 | CN102847144A Body immune function-enhancing cell biological drug, its preparation method and application |
| 01/02/2013 | CN102847143A Cell biological drug for allogeneic adoptive cellular immunotherapy of blood system diseases and preparation method |
| 01/02/2013 | CN102399724B Haemophilus parasuis LC strain and application thereof |
| 01/02/2013 | CN102268446B Tubercle bacillus Ag85ab mosaic gene vaccine and preparation method and application thereof |
| 01/02/2013 | CN102154348B Vibrio anguillarum and edwardsiella tarda-resistant multi-valence live vaccine, correlative expression vector and application |
| 01/02/2013 | CN102038960B Method for preparing outer membrane protein H and A genes of fowl cholera and fused DNA vaccine |
| 01/02/2013 | CN102002049B Antigen and preparation method and application thereof |
| 01/02/2013 | CN101988058B Gene expression composition, PRRS (Porcine Reproductive and Respiratory Syndrome) oral vaccine and preparation methods thereof |
| 01/02/2013 | CN101903406B Bivalent, bispecific antibodies |
| 01/02/2013 | CN101899418B Avian influenza virus (AIV) as well as kit and vaccine used for detecting and preventing same |
| 01/02/2013 | CN101891805B Human enterovirus 71 type specific polypeptide and application thereof |
| 01/02/2013 | CN101824090B Monoclonal antibody hpam4 |
| 01/02/2013 | CN101799476B Reagent box for sieving autoantibody for tsh receptor |
| 01/02/2013 | CN101754975B Recombinant vaccine against bluetongue virus |
| 01/02/2013 | CN101563090B Use of lipid containing particles comprising quillaja saponins for the treatment of cancer |
| 01/02/2013 | CN101553244B Treatment for intimal hyperplasia and related conditions |
| 01/02/2013 | CN101428145B Novel vaccine adjuvant |
| 01/02/2013 | CN101421296B Hypoallergenic chimeric proteins belonging to the lipid transfer family of Parietaria judaica for use in the treatment of allergies |
| 01/02/2013 | CN101405027B Intranasal influenza vaccine based on virosomes |
| 01/02/2013 | CN101208101B 免疫原性组合物 The immunogenic composition |
| 01/02/2013 | CN101163500B Composition for adjuvant containing poly-gamma-glutamic acid |
| 01/02/2013 | CN101103044B Anti-alhpha 9 integrin antibody and the use thereof |
| 01/01/2013 | USRE43899 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 01/01/2013 | USRE43898 Altered antibodies and their preparation |
| 01/01/2013 | US8344114 Antagonists of PCSK9 |
| 01/01/2013 | US8344112 IGF-1R specific antibodies useful in the detection and diagnosis of cellular proliferative disorders |
| 01/01/2013 | US8344111 Human monoclonal nicotine specific antibodies |
| 01/01/2013 | US8344110 Antibodies to thymic stromal lymphopoietin (TSLP) receptor molecules and uses thereof |
| 01/01/2013 | US8344109 Anti-ricin antibody |
| 01/01/2013 | US8343761 Methods of generating and using antibody-producing cells |
| 01/01/2013 | US8343518 Preservation of bioactive materials by freeze dried foam |
| 01/01/2013 | US8343512 Treatment of allergic conditions using a composition containing synthetic adjuvant |
| 01/01/2013 | US8343511 Methods and compositions for treating inflammatory bowel disease |
| 01/01/2013 | US8343510 Protective proteins of S. agalactiae, combinations thereof and methods of using the same |
| 01/01/2013 | US8343509 Methods and compositions for detection of bacteria and treatment of diseases and disorders |
| 01/01/2013 | US8343508 Botulinum antitoxin compositions and methods |
| 01/01/2013 | US8343507 Protein from Photobacterium damselae and use thereof |
| 01/01/2013 | US8343506 Chimeric chikungunya virus and uses thereof |
| 01/01/2013 | US8343505 Subunit vaccine for aquaculture |
| 01/01/2013 | US8343504 methods and materials for treating conditions associated with IgE activation in humans and animals, and to agents capable of modulating the activation. The agents of the invention comprise or are related to IGBPMA polypeptides from ticks. |
| 01/01/2013 | US8343503 Contiguous overlapping peptides for treatment of birch pollen allergy |
| 01/01/2013 | US8343502 Yeast-based vaccines as immunotherapy |
| 01/01/2013 | US8343500 Peptide composition |
| 01/01/2013 | US8343499 Anti-arthropod vector vaccines, methods of selecting and uses thereof |
| 01/01/2013 | US8343498 Adjuvant incorporation in immunonanotherapeutics |
| 01/01/2013 | US8343497 Targeting of antigen presenting cells with immunonanotherapeutics |
| 01/01/2013 | US8343496 Anti-CD74 immunoconjugates and methods |
| 01/01/2013 | US8343495 Equine antibodies against Bacillus anthracis for passive immunization and treatment |
| 01/01/2013 | US8343494 Antibodies against LLG polypeptides of the triacylglycerol lipase family |
| 01/01/2013 | US8343493 Antibodies specific of the β-amyloid peptides and their uses as diagnostic agents or drugs |
| 01/01/2013 | US8343492 Method for blocking binding of CX3C chemokines using CX3C chemokine antibodies |
| 01/01/2013 | US8343491 Anti-HIMF antibodies to treat lung diseases |
| 01/01/2013 | US8343490 Monoclonal antibody SC104 and derivative thereof specifically binding to a sialyltetraosyl carbohydrate as a potential anti-tumor therapeutic agent |
| 01/01/2013 | US8343489 Methods for humanizing antibodies and humanized antibodies made thereby |
| 01/01/2013 | US8343488 Diagnosis and treatment of human dormancy-related sequellae |
| 01/01/2013 | US8343478 Parapoxviruses in combination with other antiviral agents for the treatment of viral diseases |
| 01/01/2013 | US8343476 Method of using IL-29 cystehne mutant to treat hepatitis C and hepatitis B |
| 12/27/2012 | WO2012178196A2 Protection against dengue virus and prevention of severe dengue disease |
| 12/27/2012 | WO2012178160A2 Materials and methods for modulating immune responses |
| 12/27/2012 | WO2012178137A1 Light chain immunoglobulin fusion proteins and methods of use thereof |
| 12/27/2012 | WO2012178118A1 Pharmaceutical compositions, comprising a combination of select carriers, vitamins, tannins and flavonoids as antigen-specific immuno-modulators |
| 12/27/2012 | WO2012178083A1 Methods of treating chronic disorders with complement inhibitors |
| 12/27/2012 | WO2012178078A2 Use of yscf, truncated yscf and yscf homologs as adjuvants |
| 12/27/2012 | WO2012177972A1 Anti-alpha synuclein binding molecules |